Bavarian Nordic

This study tests whether the MVA-BN mpox vaccine works just as well when made in a different type of cell. About 970 healthy adults aged 18 to 49 will receive two doses. Researchers will compare immune responses and side effects between the standard and new production methods.

This study tests whether the MVA-BN vaccine, already used in adults, works safely in children aged 2 to 12 to prevent mpox, smallpox, and similar viruses. About 460 participants, including children and adults, will receive two doses four weeks apart. Researchers will measure immu…

This study tests a new vaccine designed to protect healthy adults from two rare but serious mosquito-borne viruses that can cause brain swelling (encephalitis). The trial involves 411 participants and aims to find the best dose and schedule for the vaccine. Researchers will measu…